Jazz’s Ziihera Shows ‘Practice-Changing’ Efficacy in Stomach Cancer

Jazz’s Ziihera and BeOne’s Tevimbra plus chemotherapy led to what Truist Securities dubbed one of the strongest overall survival signals ever reported in a type of gastroesophageal cancer.